تعرف على تقنية الشحن السريع PD
اليوم نقدم لكم تقنية شحن...
Amprion Secures More Capital to Advance Novel Neurologic Diagnostics to Market
Amprion Secures More Capital to Advance Novel Neurologic Diagnostics to MarketA global biotechnology company focused on developing diagnoses for neurodegenerative disorders, Amprion, has secured $6 million in the initial close of its $15 million series B funding round. According to the company’s announcement last week, the initial phase of the funding round was spearheaded by Formation Venture Engineering (FVE), with significant contributions from Eli Lilly and Company, alongside its Series A investors.
Please login to comment on this Post